Top Industry Leaders in the Oral Cancer Diagnostics Market
Latest Oral Cancer Diagnostics Companies Update:
OralDNA Labs received FDA approval for their OraSure® HSV-1/2 Assay, a rapid point-of-care test for detecting oral herpes simplex virus (HSV) infections, a potential risk factor for oral cancer.
VizDx launched their OralScan® device, utilizing fluorescence visualization technology to identify suspicious oral lesions potentially indicative of early-stage cancer.
MDx Oral Diagnostics continues to refine their OnkoSight® Oral Cancer Test, a gene expression profiling test assisting in cancer diagnosis and treatment planning.
Quest Diagnostics introduced their Oral Cancer Risk Panel, providing a comprehensive approach to risk assessment beyond traditional visual examination.
List of Oral Cancer Diagnostics Key companies in the market
- Thermo Fisher Scientific Inc. (U.S.)
- Hoffmann-La Roche Ltd (Switzerland)
- Vigilant Biosciences, Inc. (U.S.)
- Koninklijke Philips NV (Netherlands)
- Hitachi Ltd (Japan)
- Philips NV (Netherlands)
- QIAGEN (Germany)
- E. Healthcare (U.S.)
- Recent Developments
- Koninklijke Philips NV (Netherlands)
- PeriRx, LLC (U.S.)